Beginning October 23, investigators will present their latest research at the ESMO Congress 2026. Here are some studies we’re ...

Cancer Therapy Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve ...

In this study, researchers aimed to determine whether an association exists between primary care physician availability and metastatic cancer at initial diagnosis.

Investigators explored how patient age affects clinician-delivered information on colorectal cancer screening.

Rural areas had faster increases in distant-stage incidence rates, slower decreases in mortality for cancers amenable to early detection ...

In this retrospective cohort study, researchers evaluated implementation of a carboplatin allocation plan during a carboplatin shortage.

In this analysis, researchers aimed to estimate patterns of prostate cancer among transgender women receiving gender-affirming hormone therapy, relative to those of cisgender men.

New ACOG guidance says benefits outweigh risks for most women, with nonhormonal options for those who can’t take hormones ...

In this study, researchers calculated a national estimate of lung cancer screening-eligible individuals, including estimates based on demographic variables and geographic regions.

In this phase3 trial, researchers explored whether a chemotherapy-free strategy was superior to a tyrosine kinase inhibitor plus chemotherapy in Ph-positive ALL.

(HealthDay News) — Adverse family outcomes are reported in children with B-cell acute lymphoblastic leukemia (B-ALL), according to a study published in the Journal of the National Comprehensive Cancer ...

The application for the next-generation mitomycin formulation is supported by 3-month complete response data from the phase 3 UTOPIA trial.